These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.
    Author: Miele L, Giorgio V, Alberelli MA, De Candia E, Gasbarrini A, Grieco A.
    Journal: Curr Cardiol Rep; 2015 Dec; 17(12):120. PubMed ID: 26497040.
    Abstract:
    Gut microbiota has been recently established to have a contributory role in the development of cardiometabolic disorders, such as atherosclerosis, obesity, and type 2 diabetes. Growing interest has focused on the modulation of gut microbiota as a therapeutic strategy in cardiovascular diseases and metabolic disorders. In this paper, we have reviewed the impact of gut microbiota on metabolic disorders and cardiovascular disease risk, focusing on the newest findings in this field.
    [Abstract] [Full Text] [Related] [New Search]